News
Retinal Physician: What’s Next in Wet AMD Therapy?
SUBSPECIALTY NEWS
April 1st, 2013
April 1st, 2013
Retina Today: Integrin Peptide Therapy for the Treatment of Vascular Eye Diseases
Baruch D. Kuppermann, MD, PhD
March 13, 2013
March 13, 2013
Retinal Physician: Integrin Peptides: a New Type of Anti-VEGF
Jerry Helzner, Senior Editor
October 1st, 2012
October 1st, 2012
Retina Today: Integrin Peptide Therapy
Dr. David Boyer
September/October 2012
September/October 2012
BioPharm Insight : Allegro evaluates four CROs and six partners for wAMD/DME drug ALG1001
Casey McDonald
October 2012
October 2012
Primary Care Optometry News: Phase 1b/2a study initiated with integrin peptide therapy for wet AMD
Staff
July 2012
July 2012
OSN Retina Latin America Edition : Estudio de fase 1b/2a se inició con terapia peptídica con integrina para la DMRE exudativa
Publication Staff
July/August 2012
July/August 2012
Allegro Ophthalmics: Allegro Ophthalmics To Present New Research Findings For The Treatment Of Neovascular Eye Disease At Annual ARVO Meeting And Announce Commencement Of Phase 1B/2A Study In Wet Age-Related Macular Degeneration
Publication Staff
June 2012
June 2012
OSN Retina Latin America Edition: La investigación de la retina se centra en la patología de enfermedad subyacente
Publication Staff
May/June
May/June
Retina CME: On the Scene at ARVO: Interview with David S. Boyer, MD
Vindico Medical Education
May 2012
May 2012